DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV Technologies ...

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV - ISIN: FR0010417345 ...

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

Sanofi’s tolebrutinib has been shown to delay disability progression in multiple sclerosis (MS) patients, according to phase ...

A scientific statement has been published by the AHA regarding cardiovascular toxicity in patients treated for childhood cancer.

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

Our Bureau, Chennai Monday, April 7, 2025, 11:30 Hrs [IST] ...

A groundbreaking collagen-based dermal filler has officially launched in the Philippines, promising a new approach to facial ...

Analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for shares of Omeros in a research report issued to clients and investors on Wednesday, April 2nd. Cantor Fitzgerald analyst O.

Ancient viral infections have left endogenous retroviruses in our DNA, impacting genomic evolution and playing roles in ...